Disease mechanisms in psoriasis and psoriatic arthritis.

被引：5

作者：

Costello P. ^{[1
]}

FitzGerald O. ^{[1
]}

机构：

[1] Department of Rheumatology, St. Vincent's University Hospital, Elm Park

来源：

Current Rheumatology Reports | 2001年 / 3卷 / 5期

关键词：

Psoriasis; Human Leukocyte Antigen; Dermatol; Psoriatic Arthritis; Natural Killer Receptor;

D O I：

10.1007/s11926-996-0013-7

中图分类号：

学科分类号：

摘要：

Any hypothesis that tries to explain disease mechanisms in psoriasis and psoriatic arthritis (PsA) must take into account the containment of the inflammatory process to three specific sites: the skin, synovium, and enthesis. This article reviews the recent literature that advances our understanding of disease mechanisms at these specific sites. Additional progress will be achieved by research that focuses on common pathogenic pathways at these sites, in particular when searching for foreign candidates or auto-antigens triggering the T-cell-mediated immune response.

引用

页码：419 / 427

页数：8

共 178 条

[51]

Mahfood JP(2000)Co-expression of angiopoietin and VEGF determines vascular morphology in inflammatory arthritides Arthritis Rheum 43 S1183-S1183

[52]

Brown DW(2000)Vascular endothelial growth factor and receptor expression in human inflammatory joint disease Arthritis Rheum 43 S354-S354

[53]

Baker BS(1999)Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis Br J Dermatol 141 1054-1060

[54]

Ovigne JM(1999)Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis Arthritis Rheum 42 622-630

[55]

Yamamoto T(1999)Psoriatic arthritis: a unified concept twenty years on Arthritis Rheum 42 1080-1086

[56]

Katayama I(1998)Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy Arthritis Rheum 41 694-700

[57]

Nishioka K(2000)Psoriatic arthritis—an enthesopathy-based disorder. Comment on the article by McGonagle et al Arthritis Rheum 43 712-714

[58]

Thomssen H(2000)Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody Clin Exp Dermatol 25 195-197

[59]

Hoffmann B(2000)Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study J Am Acad Dermatol 43 595-604

[60]

Schank M(2000)Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis J Am Acad Dermatol 42 428-435

← 1 2 3 4 5 6 7 8 9 10 →